Alzamend Neuro
Stock Forecast, Prediction & Price Target
Alzamend Neuro Financial Estimates
Alzamend Neuro Revenue Estimates
Alzamend Neuro EBITDA Estimates
Alzamend Neuro Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 4/30/2022 | 4/30/2023 | 4/30/2024 | 4/30/2026 | 4/30/2027 | 4/30/2028 | |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $31.55M Low: $31.55M High: $31.55M avg. 0% | Avg: $132.70M Low: $132.70M High: $132.70M avg. 320.61% | |
Net Income
% change YoY
| $-12.40M N/A | $-14.87M -19.94% | $-9.94M 33.13% | Avg: $-26.23M Low: $-3.64M High: $-3.64M avg. -163.71% | Avg: $-9.52M Low: $-1.30M High: $-1.30M avg. 63.68% | Avg: $9.03M Low: $9.03M High: $9.03M avg. 194.84% | |
EBITDA
% change YoY
| $-12.31M N/A | $-14.84M -20.55% | $-9.88M 33.40% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | |
EPS
% change YoY
| -$2.09 N/A | -$22.89 -995.21% | -$14.72 35.69% | Avg: -$0.56 Low: -$0.56 High: -$0.56 avg. 96.19% | Avg: -$0.2 Low: -$0.2 High: -$0.2 avg. 64.28% | Avg: $1.39 Low: $1.39 High: $1.39 avg. 794.99% | |
Operating Expenses
% change YoY
| $12.31M N/A | $14.87M 20.70% | $9.93M -33.17% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | |
FAQ
What is Alzamend Neuro stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 31.60% in 2026-2028.
We have gathered data from 1 analysts. Their low estimate is -3.64M, average is -26.23M and high is -3.64M.
What is Alzamend Neuro stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 106.87% in 2026-2028.
We have gathered data from 1 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Alzamend Neuro stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 318.49% in 2026-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.56, average is -$0.56 and high is $-0.56.